Captopril suppression test
Captopril Suppression Test
The Captopril Suppression Test (pronounced: cap-toe-pril suh-preh-shun test) is a diagnostic procedure used primarily in the field of Endocrinology to evaluate for Primary Aldosteronism, a condition characterized by excessive secretion of the hormone aldosterone from the adrenal glands.
Etymology
The term "Captopril" is derived from the chemical name (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid. It is a type of ACE inhibitor used in the test. "Suppression" refers to the intended effect of the medication on aldosterone production.
Procedure
The Captopril Suppression Test involves the oral administration of Captopril, an ACE inhibitor, and subsequent measurement of blood pressure and blood levels of aldosterone and renin. An abnormal response to the test (i.e., lack of expected suppression of aldosterone) suggests the presence of Primary Aldosteronism.
Related Terms
See Also
External links
- Medical encyclopedia article on Captopril suppression test
- Wikipedia's article - Captopril suppression test
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski